Fig. 3From: The amount of late gadolinium enhancement outperforms current guideline-recommended criteria in the identification of patients with hypertrophic cardiomyopathy at risk of sudden cardiac deathSurvival analysis through Kaplan-Meier according to the ACCF/AHA, HCM Risk-SCD and LGE classificationsBack to article page